A single-payer system: How does impact the medical landscape?
A revolution is afoot and the disrupting waves are influencing all sectors. The mystery is how all of this will play out on the national
A revolution is afoot and the disrupting waves are influencing all sectors. The mystery is how all of this will play out on the national
Just last week, the Trump administration delivered some surprising news. One of their flagship promises, to remove drug rebates related to Medicare and Medicaid, was
Gene and cell therapies Nothing is more exciting in medicine today than cell and gene therapy (CGT). Not that long ago, it was considered science
Now that the merger between CVS Health and Aetna is final, there is no better time to update our prior article which provided some interesting
Welcome to the second post based on the Axios program Beyond 2020: Making Care Affordable featuring leading administration, legislative, and industry stakeholders. The goal of this
Scott Gottlieb, MD being interviewed by Axios’ Bob Herman. A jam-packed hour contemplating the future of health care, just another morning in DC. The Snowfish
Around two decades ago, key opinion leader (KOL) identification and mapping was a bleeding edge concept. Hard to fathom but at the time, therapeutics companies
The recent approval of CVS Health’s merger with Aetna is being heralded as nothing less than potentially “transformational” to the health care system. Innovative ideas to streamline
Patient recruitment is a critical component for drug development. A troubling statistic from the National Institutes of Health (NIH) reports that more than 80% of
Getting to the source of all that ails you! No side effects! Learn all about it while having a great meal! When one thinks of